Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaishri Blakeley

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Current Neurology and Neuroscience Reports|June 11, 2008
Drug delivery to brain tumorsJaishri Blakeley
Current Opinion in Otolaryngology & Head and Neck Surgery|August 31, 2012
Development of drug treatments for neurofibromatosis type 2-associated vestibular schwannomaJaishri Blakeley
Advances in Neurology|April 24, 2002
Secondary causes of paroxysmal dyskinesiaJaishri Blakeley, Joseph Jankovic
Movement Disorders : Official Journal of the Movement Disorder Society|September 5, 2002
Secondary paroxysmal dyskinesiasJaishri Blakeley, Joseph Jankovic
Current Treatment Options in Neurology|June 27, 2008
Anaplastic oligodendrogliomaJaishri Blakeley, Stuart Grossman
Expert Opinion on Drug Metabolism & Toxicology|October 26, 2010
Microdialysis for assessing intratumoral drug disposition in brain cancers: a tool for rational drug developmentJaishri Blakeley, Jana Portnow
Seminars in Radiation Oncology|June 9, 2015
Clinical Management of Seizures in Patients With Low-Grade GliomaAnna F Piotrowski, Jaishri Blakeley
Acta Neuropathologica|April 10, 2019
An update on the central nervous system manifestations of neurofibromatosis type 1J Stephen Nix, Jaishri Blakeley, Fausto J Rodriguez
Clinical Neuropathology|April 10, 2020
Intraneural perineurioma in neurofibromatosis type 2 with molecular analysisBartholomew White, Allan Belzberg, Shivani Ahlawat, et al.
Plos One|December 15, 2015
Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis PatientsKimberly Laskie Ostrow, Katelyn Donaldson, Jaishri Blakeley, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Current Neurology and Neuroscience Reports|June 11, 2008
Drug delivery to brain tumorsJaishri Blakeley
Current Opinion in Otolaryngology & Head and Neck Surgery|August 31, 2012
Development of drug treatments for neurofibromatosis type 2-associated vestibular schwannomaJaishri Blakeley
Advances in Neurology|April 24, 2002
Secondary causes of paroxysmal dyskinesiaJaishri Blakeley, Joseph Jankovic
Movement Disorders : Official Journal of the Movement Disorder Society|September 5, 2002
Secondary paroxysmal dyskinesiasJaishri Blakeley, Joseph Jankovic
Current Treatment Options in Neurology|June 27, 2008
Anaplastic oligodendrogliomaJaishri Blakeley, Stuart Grossman
Expert Opinion on Drug Metabolism & Toxicology|October 26, 2010
Microdialysis for assessing intratumoral drug disposition in brain cancers: a tool for rational drug developmentJaishri Blakeley, Jana Portnow
Seminars in Radiation Oncology|June 9, 2015
Clinical Management of Seizures in Patients With Low-Grade GliomaAnna F Piotrowski, Jaishri Blakeley
Acta Neuropathologica|April 10, 2019
An update on the central nervous system manifestations of neurofibromatosis type 1J Stephen Nix, Jaishri Blakeley, Fausto J Rodriguez
Clinical Neuropathology|April 10, 2020
Intraneural perineurioma in neurofibromatosis type 2 with molecular analysisBartholomew White, Allan Belzberg, Shivani Ahlawat, et al.
Plos One|December 15, 2015
Immortalized Human Schwann Cell Lines Derived From Tumors of Schwannomatosis PatientsKimberly Laskie Ostrow, Katelyn Donaldson, Jaishri Blakeley, et al.
Pageof 6